Remove Cardiovascular Disease Remove General Cardiology Remove Strokes
article thumbnail

How Does Exercise Prevent Heart Disease?

All About Cardiovascular System and Disorders

Exercise in a regular pattern is one of the important life style modifications which everyone can adopt to prevent or delay cardiovascular disease. Exercise helps in various ways for prevention of cardiovascular disease. Maintaining normal blood pressure also reduces the risk of stroke and myocardial infarction.

article thumbnail

Climbing More Than Five Flights of Stairs Daily Reduces Risk of Heart Disease!

All About Cardiovascular System and Disorders

Climbing More Than Five Flights of Stairs Daily Reduces Risk of Heart Disease! Climbing more than five flights of stairs every day can reduce the risk of atherosclerotic cardiovascular disease by over 20% according to a study using data from the UK Biobank, published in the journal Atherosclerosis [1].

article thumbnail

Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac

Cardiology Update

The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. The vision of heart-healthy, stroke-free, and thriving communities worldwide is achievable through proactive measures and collaborative efforts.

article thumbnail

Does Fish Oil Supplement Increase Risk of Stroke and Atrial Fibrillation?

All About Cardiovascular System and Disorders

General information is that fish oil supplements are beneficial for cardiovascular health. Recommendation from UK National Institute for Health and Care Excellence is that people with or at high risk of cardiovascular disease consume at least one portion of oily fish a week.

article thumbnail

CLEAR Trial of Bempedoic Acid

All About Cardiovascular System and Disorders

CLEAR trial was a double blind, randomized, placebo controlled trial of patients who were unable or unwilling to take statins due to unacceptable adverse effects and had or were at high risk for cardiovascular disease. CLEAR trial had patients for both primary and secondary prevention of cardiovascular disease.

article thumbnail

Highlights of ACC 2024

Cardiology Update

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The primary endpoint consisted of a composite of all-cause mortality, MI, stroke, coronary revascularization, or hospitalization for unstable angina. vs. 6.2%) and stroke (2.9%

Angina 52